cryptocurrency payment network- Top Related searches

Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.The Jiading District Government of Shanghai organized statistics on the arrears of dealers. The reporter was informed that the relevant departments of the Jiading District Government of Shanghai have stepped in to count the arrears of dealers. At about 13: 00 on December 13th, the reporter of Beijing News Shell Finance saw at the registration site of Shanghai Yongqiao Village Committee that a staff member was organizing the dealers present to fill out the form, and the information collected included the name of the company, contact person, goods supplied, amount owed, due date, etc. (Shell Finance)Azure lithium battery: Robot/dog is the application field of lithium battery that the company pays close attention to. At present, only a few shipments are used in this field. Robot/dog is the application field of lithium battery that the company pays close attention to. At present, only a few shipments are used in this field, accounting for a small proportion. At present, power tools, cleaning appliances and electric motorcycles are the main applications.

6 Lianban Yibin Paper: The company's current P/B ratio is quite different from that of the same industry. Yibin Paper announced the abnormal fluctuation of stock trading. Since December 6, 2024, the company's stock has been trading daily for six consecutive trading days, with a cumulative increase of 77.12%. According to the data released by CSI official website, the latest P/B ratio of papermaking and packaging owned by the company is 1.69 times, and the latest P/B ratio of the company is 9.28 times. The current P/B ratio of the company is quite different from that of the same industry. Investors are advised to pay attention to risks.Zhengrong Real Estate and others were forced to execute 230 million yuan. According to the information of legal proceedings, recently, Zhengrong Real Estate Holdings Co., Ltd. and Minhou Zhenghong Real Estate Development Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 230 million yuan. The enforcement court is Fuzhou Intermediate People's Court of Fujian Province.Zhang Liling, Assistant Managing Director (Economic Research) of the Hong Kong Monetary Authority, will leave in May next year. On December 13th, the Hong Kong Monetary Authority announced that Ms. Zhang Liling, Assistant Managing Director (Economic Research), has resigned for personal reasons and will leave in May 2025. The Hong Kong Monetary Authority will arrange an open recruitment for the post of Assistant President (Economic Research), and will make a separate announcement after the recruitment process is completed.

Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Shenzhen Airport cooperated with China Airlines to build the first domestic civil aviation international transit service system. According to Shenzhen Airport, the first domestic civil aviation international transit service system jointly built by Shenzhen Airport and China Airlines was officially released recently. The system is dedicated to solving the problems of data barriers and information blind spots in the supervision of international transit passengers and luggage, which will effectively improve the security efficiency of international through flights and international transit passengers and further enhance the competitiveness of Shenzhen Airport International Aviation Hub.Syrian Human Rights Watch: Israel attacked military facilities in central Syria. On December 13, local time, Syrian Human Rights Watch said that the Israeli army launched an attack on military targets in the Mesyaf area of Hama province in central Syria and the rural area of Homs city in Homs province. (CCTV News)